- Home
- ABBV vs CAT Comparison
ABBV vs CAT Comparison
Compare ABBV & CAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | CAT |
|---|---|---|
| Founded | 2012 | 1925 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 405.3B |
| IPO Year | 2012 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ABBV | CAT |
|---|---|---|
| Price | $224.41 | $910.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 19 |
| Target Price | $253.71 | ★ $714.42 |
| AVG Volume (30 Days) | ★ 3.9M | 2.4M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.39% | 0.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.39 | ★ 5.47 |
| Revenue | $61,160,000,000.00 | ★ $67,589,000,000.00 |
| Revenue This Year | $11.87 | $10.42 |
| Revenue Next Year | $8.12 | $8.64 |
| P/E Ratio | $582.69 | ★ $166.30 |
| Revenue Growth | ★ 8.57 | 4.29 |
| 52 Week Low | $181.75 | $355.70 |
| 52 Week High | $244.81 | $946.83 |
Technical Indicators
Market Signals| Indicator | ABBV | CAT |
|---|---|---|
| Relative Strength Index (RSI) | 63.40 | 56.47 |
| Support Level | $220.11 | $849.46 |
| Resistance Level | $231.00 | $931.35 |
| Average True Range (ATR) | 5.05 | 26.95 |
| MACD | 1.25 | -0.97 |
| Stochastic Oscillator | 72.68 | 65.21 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About CAT Caterpillar Inc.
Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. Its reporting segments are construction, resource, energy, and transportation. Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has a global reach that is approximately evenly balanced between the US and the rest of the world. Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of over 150 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.